Lululemon shares tumble on weak US demand, tariff woes

Lululemon Athletica (LULU.O) shares plunged over 17% in premarket trading after the company slashed its annual profit and sales forecasts for the second consecutive quarter, citing tepid U.S. demand, market share loss to rivals, and a $240 million impact from tariffs. The athletic wear maker reported a 1% decline in comparable sales for its Americas segment, prompting analysts to suggest that weakening U.S. performance and rising competition could permanently impair its earnings per share, reflecting broader challenges in consumer discretionary spending.

Analysis

Lululemon Athletica (LULU.O) is facing a significant crisis of confidence, evidenced by a premarket share price plunge of over 17% following its second consecutive downward revision of annual profit and sales forecasts. The guidance cut is substantial, with the annual profit per share forecast slashed from a range of $14.58-$14.78 to $12.77-$12.97. This revision is driven by a confluence of internal and external pressures, most notably a 1% decline in comparable sales in the Americas, its largest market, which starkly contrasts with 15% growth in international sales. Management has acknowledged internal missteps, with CEO Calvin McDonald admitting that core product life cycles have been allowed to run too long, weakening their competitive edge. These operational issues are compounded by external headwinds, including a projected $240 million impact on 2025 gross profit from tariffs and the removal of the de minimis exemption, signaling a structural margin pressure. The market's deep pessimism, reflected in a 40% year-to-date stock decline and a forward P/E multiple of 13.82—well below Nike's 39.21—indicates that investors are pricing in a scenario where, as one analyst noted, rising competition could permanently impair the company's earnings power.

Key Decisions for Investors

• Given the second consecutive guidance cut and a 1% decline in core US comparable sales, investors with a bearish outlook may see this as confirmation of a deteriorating fundamental story beyond just cyclical pressures.
• Investors should closely monitor the divergence between the declining Americas segment and the growing international business, as stabilization or improvement in US sales is now critical to justify a long position.
• The stock's low forward P/E of 13.82 relative to peers warrants a cautious evaluation of whether the valuation fully reflects the newly quantified $240 million tariff impact on future gross profit and the acknowledged product line weaknesses.